Editas Medicine
EDIT
EDIT
250 hedge funds and large institutions have $465M invested in Editas Medicine in 2022 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 64 increasing their positions, 68 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
21% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 53
21% less capital invested
Capital invested by funds: $591M → $465M (-$126M)
Holders
250
Holding in Top 10
–
Calls
$15.7M
Puts
$10.8M
Top Buyers
| 1 | +$25.5M | |
| 2 | +$18.4M | |
| 3 | +$3.57M | |
| 4 |
BlackRock
New York
|
+$3.16M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.03M |
Top Sellers
| 1 | -$4.61M | |
| 2 | -$4.36M | |
| 3 | -$4.36M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$2.94M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.47M |